Arformoterol Tartrate Solution
Product Images NDC 50742-395

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 50742-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Outercarton60 (20250305111738)

Outercarton60 (20250305111738)
This is a description of Arformoterol Tartrate Inhalation Solution, which is a medication used for oral inhalation. The solution comes in sterile unit-dose vials with a potency of 15 meg per 2 mL. It is important to keep the solution refrigerated or store it at room temperature for up to 6 weeks. The solution is sensitive to light, excessive heat, and should be protected from these elements. It is advisable to use the medication as directed by a healthcare provider and not exceed the recommended dosage. Additionally, it is stressed to keep the solution out of reach of children. The manufacturer of this solution is Ingenus Pharmaceuticals, LLC, with an office location in Florida.*
FDA Label Image

Outercarton30 (20250305111923)

Outercarton30 (20250305111923)
This text provides information about Arformoterol Tartrate Inhalation Solution in 2 mL unit-dose vials. Each vial contains 15 mcg of arformoterol. It is for oral inhalation only and should be stored refrigerated or at room temperature for up to 6 weeks. The solution is light-sensitive and should be protected from excessive heat. The manufacturer is not mentioned, but the text indicates it is manufactured for "Genus Pharmaceuticals, LLC." The instructions advise storing unopened pouches in a refrigerator or at room temperature. It is important to follow the recommended dosage and expiration date. Additionally, the solution is not child-resistant, so it should be kept out of reach of children.*
FDA Label Image

Image 1 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 1)

Image 1 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 1)
FDA Label Image

Image 2 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 2)

Image 2 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 2)
FDA Label Image

Image 3 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 3)

Image 3 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 3)
FDA Label Image

Image 4 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 4)

Image 4 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 4)
FDA Label Image

Image 5 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 5)

Image 5 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 5)
FDA Label Image

Image 6 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 6)

Image 6 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 6)
FDA Label Image

Clinical Figure 1 (Clinical Figure 1)

Clinical Figure 1 (Clinical Figure 1)
This text provides information on a study comparing the effect of 15 mcg arformoterol tartrate inhalation solution BID and a placebo on change from baseline FEV1 (Forced Expiratory Volume in 1 second) in individuals. The study was conducted with 143 participants in the placebo group and 141 participants in the arformoterol tartrate group. The baseline FEV1 value for the placebo group was 1.20 (L) while for the arformoterol tartrate group it was 1.15 (L).*
FDA Label Image

Clinical Figure 1 (Clinical Figure 2)

Clinical Figure 1 (Clinical Figure 2)
This text provides data on the mean change from baseline Forced Expiratory Volume (FEV) in liters for two different treatments: placebo and 15 mcg arformoterol tartrate inhalation solution BID. It includes the number of participants in each group and their baseline FEV values.*
FDA Label Image
Logo (Ingenus Logo)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.